Substance Use Tools & Resources    

This inaugural Strategy proposes bold, targeted, and consequential actions to bend the curve on overdose deaths in the immediate term and reduce drug use and its damaging consequences over the longer term.

This document summarizes a discussion from a workshop where experts examined the evidence for candidate endpoints and study design strategies for clinical trials of stimulant use disorder treatments.

Provides recommendations for clinicians providing pain care, including those prescribing opioids, for outpatients aged ≥ 18 years. It updates the CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.

Helps providers apply recommendations to clinical practice by putting the entire guideline, tools, and resources in an app. Includes a morphine milligram equivalent calculator, summaries of key recommendations, a link to the full guideline, and an interactive motivational interviewing feature to help providers practice effective communication skills and prescribe with confidence.

This document summarizes the discussion from the meeting of clinicians and researchers who are knowledgeable about screening for fentanyl and other drugs, primarily in health care settings. The focus of the meeting was to understand clinician/researcher perspectives about clinical fentanyl testing and distribution of fentanyl test strips (FTS) to patients and discuss next steps for technology development, research, and practice.

These proceedings summarize the discussion from the harm reduction community roundtable and supplemental individual interviews, inclusive of representatives from national and local harm reduction organizations, state and local government agencies, tribal organizations, and researchers who have experience distributing fentanyl test strips (FTS) or are knowledgeable about FTS specifically or drug checking more generally.

The FDA Overdose Prevention Framework consists of four overarching priorities that align with the U.S. Department of Health & Human Services' Overdose Prevention Strategy to address the public health emergency as it continues to evolve.

This FDA page provides an index of over 400 FDA approved drugs and their descriptions. Note that it does not include all FDA approved drugs, but shares other resources to find more information on drugs not included on the list.

This was a two-day virtual public workshop (which can now be re-watched) that focused on identifying gaps in existing opioid prescriber education offerings and core competencies that should be included in educational content for opioid prescribers and other healthcare providers, including prescriber education under a Risk Evaluation and Mitigation Strategy (REMS).

The Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, is an aggressive, trans-agency effort to speed scientific solutions to stem the national opioid public health crisis.